the Visualase System
The Visualase® System is a revolutionary tool for the destructive treatment of cancer or other malignancies using laser-generated heat. Laser-induced interstitial thermal therapy (LITT) is a minimally
invasive therapy for the treatment of solid tumors that uses laser light to destroy the affected tissue through heat. Visualase® utilizes a powerful image-guided system to target tumors and to visualize thermal therapy in real time.
What Visualase Offers:
- Minimally-invasive laser-based therapy and MRI-guided workstation for destruction of tumors.
- Surgeon can target and destroy only the tumor, leaving surrounding healthy tissue unharmed.
- Increases patient comfort, improves patient outcomes and reduces healthcare costs.
- Performed under local anesthesia
- Laser delivery lasts typically < 5 minutes
- Upon treatment completion, patient immediately undergoes MRI, allowing confirmation of thermal ablation zone
Incidence of Brain Tumors:
- Each year over 200,000 patients are newly diagnosed with brain tumors in the United States.
- Roughly 17,000 of these tumors are “benign,” meaning that the tumor mass is not cancerous, although threat to life and/or brain function may exist. Benign tumors are often treatable.
- The rest – over 187,000 – are malignant (cancerous) and are usually capable of causing or contributing to patient death and/or significant impairment.
- The number of newly diagnosed malignant brain tumors approaches 400,000 per year when including Europe and Canada.
Read more about: treatments | technology | clinical trials | products